ethinyl estradiol has been researched along with Bowel Diseases, Inflammatory in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edsall, RJ; Harris, HA; Henderson, RA; Keith, JC; Manas, ES; Mewshaw, RE; Xu, ZB; Yang, C | 1 |
| Borges-Marcucci, L; Brazzale, A; Caggiano, TJ; Chadwick, CC; Chippari, S; Eckert, A; Harnish, DC; Ho, DM; Keith, JC; Kenney, T; Kraml, CM; Trybulski, E | 1 |
| Weisberg, E | 1 |
3 other study(ies) available for ethinyl estradiol and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Estrogen Receptor beta; Female; Genistein; Humans; Inflammatory Bowel Diseases; Ligands; Male; Models, Molecular; Molecular Conformation; Molecular Mimicry; Molecular Structure; Naphthalenes; Naphthols; Organ Size; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Transcription, Genetic; Uterus | 2005 |
Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthriti
Topics: Administration, Oral; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Experimental; Cell Line; Creatine Kinase; Crystallography, X-Ray; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Inflammatory Bowel Diseases; Luciferases; Mice; NF-kappa B; Nitriles; Propionates; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Transcriptional Activation | 2007 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |